LobbyingOrca Bio lobbying by quarter
Orca Bio's latest lobbying report covers Q2 2026, at $70K. Its first report covers Q2 2026; the issues it reports most are Medical/Disease Research/Clinical Labs and Budget/Appropriations.
Orca Bio
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $70K
- Last 2 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2026 | $70K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$60K · 2 reports
- Budget and appropriations$10K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Executive Office of the President (EOP)1 reports
- Food & Drug Administration (FDA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| BGR Government Affairs | $50K | 1 quarters |
| Adams and Reese | $20K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q2 2026 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q2 2026 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | BGR Government Affairs | $50K |
| 07/14for Q2 | Adams and Reese | $20K |
| 06/15for Q2 | BGR Government Affairs | Under $5,000 |
| 04/28for Q2 | Adams and Reese | Under $5,000 |